DUBLIN--(BUSINESS WIRE)--The "Clinical Decision Support Systems Market by Component, Delivery Mode, Product, Application, Model, Type, Interactivity, Patient Care Setting - Global Forecasts to 2023" report has been added to ResearchAndMarkets.com's offering.
The clinical decision support systems market is expected to reach USD 1,752.0 million by 2023 from USD 1,001.9 million in 2018, at a CAGR of 11.8%.
Growth in the market is primarily driven by the government support and initiatives to drive adoption of HCIT solutions in healthcare, rising incidence of medication errors, rising prominence and usage of big data and mhealth tools, growing adoption of cloud computing in healthcare and partnerships between medical research groups & clinical decision support companies. However, reluctance to adopt mobile CDSS, high investments for IT infrastructure, data security concerns related to cloud-based CDSS, and lack of interoperability is likely to restrain the market to certain extent.
On the basis of application, the market has been segmented into conventional and advanced CDSS. In 2017, the conventional CDSS segment commanded the largest share of the global CDSS market. However, the advanced CDSS segment is estimated to grow at the highest rate in the forecast period. This is owing to these systems performing additional functions such as population health management, financial decision support, assisting clinicians in real-time evidence-based decision making, treatment planning, and protocol validation.
Based on product, the clinical decision support systems (CDSS) market is segmented into integrated CDSS and standalone CDSS. Of these, the integrated CDSS segment accounted for the largest market share in 2017. The large share of this segment is majorly attributed to the growing deployments of integrated CDSS. Integrated CDSS are widely used by healthcare providers as they improve the quality of care and health outcomes and reduce medication errors. While using integrated solutions, users can easily switch from one type of application to another without exiting the program.
Factors such as the presence of a large patient population demanding better healthcare at lower costs, economic growth, implementation of favorable government policies, increasing spending on IT infrastructure by healthcare providers, and growing focus of various market players on emerging Asian countries are driving the growth of the market in this region.
Wolters Kluwer Health (US), Hearst Health (US), and Elsevier B.V. (Netherlands) are the leading players in the market. Other prominent players include Cerner Corporation (US), McKesson Corporation (US), Epic Systems Corporation (US), MEDITECH (US), Philips Healthcare (Netherlands), International Business Machines (IBM) (US), and Allscripts Healthcare Solutions, Inc. (US).
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Case Studies
7 Clinical Decision Support Systems Market, By Component
8 Clinical Decision Support Systems Market, By Product
9 Clinical Decision Support Systems Market, By Type
10 Clinical Decision Support Systems Market, By Model
11 Clinical Decision Support Systems Market, By Delivery Mode
12 Clinical Decision Support Systems Market, By Application
13 Clinical Decision Support Systems Market, By Level of Interactivity
14 Clinical Decision Support Systems Market, By Setting
15 Global Clinical Decision Support Systems Market, By Region
16 Competitive Landscape
17 Company Profiles
- Allscripts Healthcare Solutions
- Elsevier B.V. (A Division of Relx Group)
- Epic Systems
- Hearst Health
- Philips Healthcare (A Subsidiary of Royal Philips Electronics)
- Wolters Kluwer Health
For more information about this report visit https://www.researchandmarkets.com/research/dfsldz/clinical_decision?w=4